Epilepsia – December 2022 – Announcements.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3216, doi. 10.1111/epi.17458
- Publication type:
- Article
Works matching IS 00139580 AND DT 2022 AND VI 63 AND IP 12
Results: 26
1
2
Corrigendum to "Brain network excitatory/inhibitory imbalance is a biomarker for drug‐naive Rolandic epilepsy: A radiomics strategy". [Epilepsia 2021, 62 (10): 2426–2438].
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3215, doi. 10.1111/epi.17443
- Publication type:
- Article
3
The nuances of immunotherapy for NORSE/FIRES.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3212, doi. 10.1111/epi.17439
- By:
- Publication type:
- Article
4
Seizures in anti‐Hu–associated extra‐limbic encephalitis: Characterization of a unique disease manifestation.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. e172, doi. 10.1111/epi.17437
- By:
- Publication type:
- Article
5
Association between the risk of seizure and COVID‐19 vaccinations: A self‐controlled case‐series study.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3100, doi. 10.1111/epi.17436
- By:
- Publication type:
- Article
6
Progressive slowing of clonic phase predicts postictal generalized EEG suppression.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3204, doi. 10.1111/epi.17434
- By:
- Publication type:
- Article
7
Altered cerebellar‐motor loop in benign adult familial myoclonic epilepsy type 1: The structural basis of cortical tremor.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3192, doi. 10.1111/epi.17430
- By:
- Publication type:
- Article
8
A systems medicine strategy to predict the efficacy of drugs for monogenic epilepsies.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3125, doi. 10.1111/epi.17429
- By:
- Publication type:
- Article
9
Neurobehavioral deficits and a progressive ictogenesis in the tetrodotoxin model of epileptic spasms.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3078, doi. 10.1111/epi.17428
- By:
- Publication type:
- Article
10
Successful treatment of adult Dravet syndrome patients with cenobamate.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. e164, doi. 10.1111/epi.17427
- By:
- Publication type:
- Article
11
Seizure outcome determinants in children after surgery for single unilateral lesions on magnetic resonance imaging: Role of preoperative ictal and interictal electroencephalography.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3168, doi. 10.1111/epi.17425
- By:
- Publication type:
- Article
12
Acute symptomatic seizures secondary to myelin oligodendrocyte glycoprotein antibody‐associated disease.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3180, doi. 10.1111/epi.17424
- By:
- Publication type:
- Article
13
Lacosamide decreases neonatal seizures without increasing apoptosis.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3051, doi. 10.1111/epi.17423
- By:
- Publication type:
- Article
14
Bone development in offspring of pregnant rats treated with carbamazepine: Evaluation by three different methods.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3066, doi. 10.1111/epi.17422
- By:
- Publication type:
- Article
15
Deficit in observational learning in experimental epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. e150, doi. 10.1111/epi.17421
- By:
- Publication type:
- Article
16
Synergistic effects of the galanin analog 810–2 with the antiseizure medication levetiracetam in rodent seizure models.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3090, doi. 10.1111/epi.17420
- By:
- Publication type:
- Article
17
A gain‐of‐function GRIA2 variant associated with neurodevelopmental delay and seizures: Functional characterization and targeted treatment.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. e156, doi. 10.1111/epi.17419
- By:
- Publication type:
- Article
18
Gene panel to guide antiseizure medication prescribing: Does the cost justify the benefits?
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3122, doi. 10.1111/epi.17418
- By:
- Publication type:
- Article
19
Seizure count forecasting to aid diagnostic testing in epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3156, doi. 10.1111/epi.17415
- By:
- Publication type:
- Article
20
Paroxysmal fast activity is a biomarker of treatment response in deep brain stimulation for Lennox–Gastaut syndrome.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3134, doi. 10.1111/epi.17414
- By:
- Publication type:
- Article
21
Drug‐resistant epilepsy and mortality—Why and when do neuromodulation and epilepsy surgery reduce overall mortality.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3020, doi. 10.1111/epi.17413
- By:
- Publication type:
- Article
22
Drug resistance in idiopathic generalized epilepsies: Evidence and concepts.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3007, doi. 10.1111/epi.17410
- By:
- Publication type:
- Article
23
Early cost–utility analysis of genetically guided therapy for patients with drug‐resistant epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3111, doi. 10.1111/epi.17408
- By:
- Publication type:
- Article
24
The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3148, doi. 10.1111/epi.17407
- By:
- Publication type:
- Article
25
Functional neuropathology of neonatal hypoxia‐ischemia by single‐mouse longitudinal electroencephalography.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3037, doi. 10.1111/epi.17403
- By:
- Publication type:
- Article
26
Issue Information.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. i, doi. 10.1111/epi.16568
- Publication type:
- Article